Literature DB >> 21083078

Biomarkers: unrealized potential in sports doping analysis.

Phil Teale1, Chris Barton, Philip M Driver, Richard G Kay.   

Abstract

The fight against doping in sport using analytical chemistry is a mature area with a history of approximately 100 years in horse racing and at least 40 years in human sport. Over that period, the techniques used and the breadth of coverage have developed significantly. These improvements in the testing methods have been matched by the increased sophistication of the methods, drugs and therapies available to the cheat and, as a result, testing has been a reactive process constantly adapting to meet new threats. Following the inception of the World Anti-Doping Agency, research into the methods and technologies available for human doping control have received coordinated funding on an international basis. The area of biomarker research has been a major beneficiary of this funding. The aim of this article is to review recent developments in the application of biomarkers to doping control and to assess the impact this could make in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21083078     DOI: 10.4155/bio.09.87

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  3 in total

Review 1.  Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues.

Authors:  Bethany Keen; Adam Cawley; Brian Reedy; Shanlin Fu
Journal:  Drug Test Anal       Date:  2022-03-08       Impact factor: 3.234

2.  Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Kathy Tou; Adam Cawley; Christopher Bowen; Kireesan Sornalingam; Shanlin Fu
Journal:  Drug Test Anal       Date:  2022-03-04       Impact factor: 3.234

3.  Multiple protein biomarker assessment for recombinant bovine somatotropin (rbST) abuse in cattle.

Authors:  Susann K J Ludwig; Nathalie G E Smits; Grishja van der Veer; Maria G E G Bremer; Michel W F Nielen
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.